Preliminary Report on the Efficacy of Music Therapy to Optimize the Compliance of Rett Syndrome Patients Attending Oral Hygiene Procedures

被引:1
|
作者
Tortoriello, Mario [1 ]
Frosolini, Andrea [2 ]
Pianigiani, Sara [1 ]
Cascino, Flavia [2 ]
Gabriele, Guido [2 ]
Gennaro, Paolo [2 ]
Parrini, Stefano [1 ]
Viviano, Massimo [1 ]
机构
[1] Univ Siena, Dept Med Biotechnol, Unit Oral Surg, I-53100 Siena, Italy
[2] Univ Siena, Dept Med Biotechnol, Unit Maxillo Facial Surg, I-53100 Siena, Italy
来源
PSYCHIATRY INTERNATIONAL | 2023年 / 4卷 / 03期
关键词
Rett syndrome; intellectual developmental disability; music therapy; oral hygiene; MANAGEMENT;
D O I
10.3390/psychiatryint4030023
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Individuals with intellectual developmental disability (IDD) often face barriers in accessing dental care. The main aim of the present study was to test the feasibility and the outcome of oral hygiene (OH) procedures in Rett syndrome (RS) patients, and a secondary aim was to test the utility of music therapy during dental hygiene procedures. Methods: A case group (Group 1) of female patients with RS (stage 3 of disease, age > 5 years and <18 years) and a control group of age-matched healthy females (Group 0) were formed, and subgroups received the intervention of oral hygiene combined with a music therapy (Subgroup 1M and Subgroup 0M) or standard oral hygiene (subgroup 1W and subgroup 0W). The Simplified Oral Hygiene Index (OHI-S) was used to assess the effectiveness of oral hygiene measures. Results: The OHI-S at T0 was 1.41 in Group 1 and 2.58 in Group 0 (p value < 0.001). The mean duration of the oral hygiene treatment was 7018'' (SD 3272'') in Group 1 and 873'' (SD 161'') in Group 0 (p value < 0.001). The mean duration of OH was significantly higher in Subgroup 1M and Subgroup 0M. Discussion: Based on the results of our case-control study, OH procedures can be successfully performed in RS patients with good compliance and efficacy. In addition, our study provides preliminary evidence to suggest that music therapy may be a useful adjunct, as it appears to improve patient cooperation.
引用
收藏
页码:235 / 241
页数:7
相关论文
共 37 条
  • [31] PHASE IMAGING - A NEW, NON-INVASIVE METHOD FOR DIAGNOSIS, LOCALIZATION OF ACCESSORY PATHWAYS, AND SERIAL ASSESSMENT OF THERAPY IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME - A PRELIMINARY-REPORT
    YIANNIKAS, J
    EASTWAY, RJ
    MACINTYRE, WJ
    MALONEY, JD
    GO, RT
    COOK, SA
    SUFKA, B
    CASTLE, LW
    CLEVELAND CLINIC QUARTERLY, 1982, 49 (02): : 61 - 72
  • [32] Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement -: a preliminary report
    Sun, SS
    Liu, FY
    Tsai, JJP
    Yen, RF
    Kao, CH
    Huang, WS
    RHEUMATOLOGY INTERNATIONAL, 2003, 23 (06) : 301 - 304
  • [33] Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement—a preliminary report
    S. S. Sun
    F. Y. Liu
    J. J. P. Tsai
    R. F. Yen
    C. H. Kao
    W. S. Huang
    Rheumatology International, 2003, 23 : 301 - 304
  • [34] PRELIMINARY REPORT ON THE IMPACT OF CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (OVERLAP SYNDROME)
    Moizuddin, M.
    Vujnic, S.
    Janssen, W.
    Tomic, R.
    Antonescu-Turcu, A.
    SLEEP, 2010, 33 : A166 - A166
  • [35] The DISPERSE2 trial: Safety, tolerability and preliminary efficacy of AZD6140, the first oral reversible ADP receptor antagonist, compared with clopidogrel in patients with non-ST segment elevation acute coronary syndrome
    Cannon, CP
    Husted, S
    Storey, RF
    Harrington, RA
    Hill, S
    Price, D
    Sanders, N
    Emanuelsson, H
    Peters, G
    CIRCULATION, 2005, 112 (17) : U677 - U677
  • [36] Pegylated (40 kDa) interferon alfa-2a (PEGASYS®) in combination with ribavirin, mycophenolate mofetil (CellCept®), amantadine, or amantadine plus ribavirin in patients that relapsed on Rebetron™ therapy:: A preliminary report of a randomized, multicenter efficacy and safety study
    Herrine, SK
    Brown, R
    Esposito, S
    Lok, A
    Galati, JS
    Bernstein, DE
    Campagna, J
    Pappas, SC
    GASTROENTEROLOGY, 2001, 120 (05) : A384 - A384
  • [37] Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials
    Gargiulo, Giuseppe
    Cannon, Christopher P.
    Gibson, Charles Michael
    Goette, Andreas
    Lopes, Renato D.
    Oldgren, Jonas
    Korjian, Serge
    Windecker, Stephan
    Esposito, Giovanni
    Vranckx, Pascal
    Valgimigli, Marco
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (F11) : F50 - F60